Key Statistics for LMNX
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for LMNX
- Net Income (M/USD)
Luminex Corporation develops, manufactures and markets biological testing technologies with applications throughout the clinical diagnostic and life science industries. The Company's open-architecture technologies enable large numbers of biological tests (bioassays) to be conducted and analyzed quickly and accurately.
More Company Profile & Key Executives for LMNX
|Patrick J Balthrop SrPresident/CEO||Jeremy K Bridge-CookSenior VP:Research & Dev|
|Michael F PintekSenior VP:Operations||David S ReiterVP/Secy/General Counsel|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries